ArticlePDF AvailableLiterature Review

Adenoid Cystic Carcinoma of the Base of the Tongue Metastasizing to the Scalp

Authors:

Abstract and Figures

Adenoid cystic carcinoma is a rare neoplasm that originates from secretory glands, most commonly from the salivary glands. We present a 76 year-old white man with a history of adenoid cystic carcinoma from the base of the tongue diagnosed 15 years prior to the development of the metastatic lesion on his mid-posterior scalp. The present case represents the second reported instance of an extracutaneous adenoid cystic carcinoma metastasizing to the scalp. Differentiating between a primary cutaneous adenoid cystic carcinoma and an extracutaneous adenoid cystic carcinoma metastasizing to cutaneous structures is crucial in determining prognosis and management.
Content may be subject to copyright.
UC Davis
Dermatology Online Journal
Title
Adenoid Cystic Carcinoma of the Base of the Tongue Metastasizing to the Scalp
Permalink
https://escholarship.org/uc/item/6141j293
Journal
Dermatology Online Journal, 20(3)
Authors
Saco, Michael
Howe, Nicole
Jukic, Drazen M
et al.
Publication Date
2014
License
https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Volume 20 Number 3
March 2014
Case Presentation
Adenoid Cystic Carcinoma of the Base of the Tongue Metastasizing to the Scalp
Michael Saco BS1, Nicole Howe MD2, Drazen M. Jukic MD PhD2,3,4, Carlos Muro-Cacho MD PhD4,5
Dermatology Online Journal 20 (3): 6
1Medical School, The University of South Florida Morsani College of Medicine, Tampa, Florida, 2The
Department of Dermatology, University of South Florida, Tampa, Florida, 3Chief of Dermatopathology, James
A. Haley Veterans' Hospital, Tampa, Florida, 4Department of Pathology and Cell Biology, University of South
Florida, Tampa, Florida, 5Pathology and Laboratory Medicine Service, James A. Haley Veterans' Hospital,
Tampa, Florida
Correspondence:
Michael Saco BS
University of South Florida Morsani College of Medicine
13330 USF Laurel Drive, Tampa, FL 33612
Tel: (813) 974-4744
Fax: (813) 974-2132
Email: msaco@health.usf.edu
Abstract
Adenoid cystic carcinoma is a rare neoplasm that originates from secretory glands, most commonly from the salivary glands. We
present a 76 year-old white man with a history of adenoid cystic carcinoma from the base of the tongue diagnosed 15 years prior
to the development of the metastatic lesion on his mid-posterior scalp. The present case represents the second reported instance of
an extracutaneous adenoid cystic carcinoma metastasizing to the scalp. Differentiating between a primary cutaneous adenoid
cystic carcinoma and an extracutaneous adenoid cystic carcinoma metastasizing to cutaneous structures is crucial in determining
prognosis and management.
Keywords: adenoid cystic carcinoma; cutaneous metastasis; scalp; tongue; salivary glands
Introduction
Adenoid cystic carcinoma (ACC) is a rare neoplasm that originates from secretory glands and comprises a large portion of
malignant neoplasms originating in both major and minor salivary glands. Origin from other sites, such as excretory glands of the
genital tract, lacrimal glands, and ceruminous glands, has been documented [1]. Adenoid cystic carcinoma is characteristically
associated with a prolonged clinical course and slow, progressive growth. It tends to recur locally and can metastasize regionally
and systemically years after the initial diagnosis. Approximately 35-50% of salivary gland ACCs metastasize distantly 3.1 to 7.6
years after diagnosis. The lungs are the most common sites of distant metastasis. Bone, liver, and brain are also common sites [2,
3]. Adenoid cystic carcinoma is generally treated by surgical excision with attention to margins and the presence of perineural
invasion. This is typically followed by adjuvant external radiation of the surgical bed. Results from studies evaluating the efficacy
of chemotherapy in the treatment of ACC remain inconclusive [1].
Primary cutaneous ACC is best classified as a neoplasm with sweat gland differentiation. These neoplasms can occur anywhere on
the body, but have a predilection for the scalp and chest [4, 5]. Wide local excision with free margins is the treatment choice [6],
and Mohs surgery is frequently employed [7]. Cutaneous ACC is locally invasive and 76% of the cases show perineural invasion,
resulting in local recurrence in 44% of the cases [5, 7]. Primary cutaneous ACC, however, is less aggressive than salivary gland
ACC, and distant metastases, typically to lung, are rare. Cases with metastatic spread to the pleura and lymph nodes have also
been reported. Metastases have been diagnosed from 8.2 to 16 years after diagnosis of the primary tumor [4-6]. Even though
primary cutaneous ACC has a predilection for the scalp and chest, to the authors’ knowledge, only one case of metastases from
extracutaneous ACCs to the scalp has been reported [8].
Methods
A search of PubMed performed on November 2, 2013, with the following terms “adenoid,” “cystic,” “carcinoma,” “cutaneous,
“metastasis,” “metastases,” “scalp” yielded only one report of metastases to the scalp from a primary ACC of lacrimal gland
origin.
Case synopsis
A 76 year-old white man presented to the dermatology clinic with a firm, pink papule on the mid-posterior scalp that had been
slowly growing for an indeterminate period of time (Figure 1). He had a history of non-melanoma skin cancer (NMSC) and right
base of tongue ACC with pulmonary metastases. The primary ACC was diagnosed 15 years prior to this visit and the tumor had
peri- and intraneural invasion (Figure 2). The initial treatment was surgical excision, followed one month later by a re-excision to
obtain negative margins. He received no further treatment and was followed by his oncologist. A computed tomographic (CT)
scan of the thorax with contrast, performed 2 years prior to the current date, revealed diffuse pulmonary metastases, bilaterally,
confirmed by biopsy. The biopsied metastatic lesion was diffusely positive for CD117 (c-kit). A new thoracic CT scan showed
that one of the metastases was possibly increasing in size and that the other nodules were relatively stable. The patient deferred
oncologic treatment, but agreed to be monitored via thoracic CT scans. During his visit to the dermatology clinic for an unrelated
reason, a firm, pink papule was discovered on the mid-posterior scalp and a shave biopsy was performed
Upon histopathology examination (Figures 3A and 3B), the lesion resembled a basal cell carcinoma, but a closer inspection
revealed that the neoplasm formed multiple ductal structures expressing carcinoembryonic antigen (CEA), cytokeratin (CK) 8/18
(Figure 3C), epithelial membrane antigen (EMA) (Figure 3D), and pankeratin AE1/AE3. No connection to the epidermis was
identified. At the time of this diagnosis, the pathologist was unaware of the patient’s clinical history and the diagnosis considered
was primary ACC of sweat gland differentiation. Once the pathologist learned about the patient’s history of base of tongue ACC,
the current tumor was compared to the tumor from the patient’s previous excision. The histopathologic features of the original
tumor and the scalp metastasis were almost identical, except that the metastasis lacked intraluminal globules of basement
membrane material. Accordingly, a diagnosis of metastatic ACC was made.
The tumor measured 0.8 cm in greatest dimension and was excised with 0.4 cm negative margins. After the patient had a
discussion with his oncologist, he decided that he wanted to defer workup for further metastatic lesions pending the results of
future repeat CT scans.
Figure 1. A 5 mm erythematous, slightly scaly papule on the mid-posterior scalp.
Figure 2. Primary adenoid cystic carcinoma at base of tongue; hematoxylin and eosin, original magnification x 10.
Figure 3. Metastatic adenoid cystic carcinoma to scalp. (A) No connection to epidermis observed; hematoxylin and eosin, original
magnification x 5. (B) Cellular detail; hematoxylin and eosin, original magnification x 20. (C) Ductal components outlined with cytokeratin
(CK) 8/18, original magnification x 10. (D) Ductal components outlined with epithelial membrane antigen (EMA), original magnification x 20.
Discussion
Differentiating between primary cutaneous ACC and cutaneous metastases originating from an extracutaneous ACC can be
difficult, but it has important implications for management, specifically whether chemotherapy should be added to surgical
excision [1, 6]. Distant cutaneous metastases from extracutaneous ACCs are rare and carry a poor prognosis [4, 5]. Table 1
presents all 16 cases of extracutaneous adenoid cystic carcinoma metastasizing to cutaneous sites that are documented in the
available literature, including the present case. The present case is the second reported case of an ACC metastatic to the scalp.
In general, there are no histopathological differences between a primary cutaneous ACC and a cutaneous metastasis from an
extracutaneous ACC [9]. Immunohistochemical results in cutaneous ACC closely resemble those of salivary gland ACC. One
noteworthy difference is that CEA is consistently positive in extracutaneous ACC, whereas it is only positive in half of the cases
of cutaneous ACC [5]. As is typically observed in ACC, the present case was positive for CEA, EMA and cytokeratins AE1/AE3,
CK7, and CK 8/18 [9, 10]. Interestingly, although basal cell carcinomas can stain positively for most of the aforementioned
immunohistochemical markers, basal cell carcinomas are typically negative for EMA, except for focal staining of
keratinizing/squamous areas. Thus, EMA can be very useful in differentiating between a basal cell carcinoma and ACC [11].
CD117 and focal expression of vimentin and S100 can also be observed in ACC [4, 5, 9]. Because primary cutaneous ACCs can
be misclassified as metastases, one could argue that the present case is a primary cutaneous ACC rather than a metastasis, even in
light of the nearly identical histopathology in the tumors examined. Primary cutaneous ACC, however, should only be diagnosed
with certainty if the patient does not have a history of extracutaneous ACC [5].
Conclusion
In conclusion, the present case demonstrates a rare yet relevant scenario that clinicians must consider when dealing with patients
who have a history of ACC. The distinction between primary cutaneous ACC and a metastasis originating from an extracutaneous
ACC is difficult, but it has critical implications for prognosis and selection of therapy. Primary cutaneous ACC should only be
diagnosed with certainty if the patient has no history of extracutaneous ACC. Furthermore, in addition to being monitored closely
by oncologists, patients with a history of ACC should also be followed by dermatologists with regularly scheduled total body skin
exams.
References
1. Ellington CL, Goodman M, Kono SA, Grist W, Wadsworth T, Chen AY, Owonikoko T, Ramalingam S, Shin DM, Khuri FR,
Beitler JJ, Saba NF. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007
Surveillance, Epidemiology, and End Results data. Cancer. 2012 Sep 15;118(18):4444-51. [PMID: 22294420]
2. Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, Haffty BG. Adenoid cystic carcinoma: a retrospective
clinical review. Int J Cancer. 2001 Jun 20;96(3):149-58. [PMID: 11410883]
3. Ko YH, Lee MA, Hong YS, Lee KS, Jung CK, Kim YS, Sun DI, Kim BS, Kim MS, Kang JH. Prognostic factors affecting the
clinical outcome of adenoid cystic carcinoma of the head and neck. Jpn J Clin Oncol. 2007 Nov;37(11):805-11. [PMID:
18057012]
4. Kato N, Yasukawa K, Onozuka T. Primary cutaneous adenoid cystic carcinoma with lymph node metastasis. Am J
Dermatopathol. 1998 Dec;20(6):571-7. [PMID: 9855352]
5. Naylor E, Sarkar P, Perlis CS, Giri D, Gnepp DR, Robinson-Bostom L. Primary cutaneous adenoid cystic carcinoma. J Am
Acad Dermatol. 2008 Apr;58(4):636-41. [PMID: 18342709]
6. Doganay L, Bilgi S, Aygit C, Altaner S. Primary cutaneous adenoid cystic carcinoma with lung and lymph node metastases. J
Eur Acad Dermatol Venereol. 2004 May;18(3):383-5. [PMID: 15096169]
7. Xu YG, Hinshaw M, Longley BJ, Ilyas H, Snow SN. Cutaneous adenoid cystic carcinoma with perineural invasion treated by
mohs micrographic surgery-a case report with literature review. J Oncol. 2010;2010:469049. [PMID: 20379385]
8. Jedrych J, Galan A. Multiple cutaneous metastases: a rare and late sequelae of lacrimal gland adenoid cystic carcinoma. J
Cutan Pathol. 2013 Mar;40(3):341-5. [PMID: 23899266]
9. Perez DE, Magrin J, de Almeida OP, Kowalski LP. Multiple cutaneous metastases from a parotid adenoid cystic carcinoma.
Pathol Oncol Res. 2007;13(2):167-9. [PMID: 17607381]
10. Fillies T, Werkmeister R, Packeisen J, Brandt B, Morin P, Weingart D, Joos U, Buerger H. Cytokeratin 8/18 expression
indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer. 2006;6:10. [PMID: 16412231]
11. Alhumaidi A. Practical immunohistochemistry of epithelial skin tumor. Indian J Dermatol Venereol Leprol. 2012 Nov-
Dec;78(6):698-708. [PMID: 23075638]
12. Vinod SU, Gay RM. Adenoid cystic carcinoma of the minor salivary glands metastatic to the hand. South Med J. 1979
Nov;72(11):1483-5. [PMID: 228433]
13. Fine G, Marshall RB, Horn RC, Jr. Tumors of the minor salivary glands. Cancer. 1960 Jul-Aug;13:653-69. [PMID: 13822849]
14. Weitzner S. Adenoid cystic carcinoma of submaxillary gland metastatic to great toe. Am Surg. 1975 Oct;41(10):655-8.
[PMID: 1163909]
15. Osborn DA. Morphology and the natural history of cribriform adenocarcinoma (adenoid cystic carcinoma). J Clin Pathol.
1977 Mar;30(3):195-205. [PMID: 191474]
16. Nascimento AG, Amaral AL, Prado LA, Kligerman J, Silveira TR. Adenoid cystic carcinoma of salivary glands. A study of
61 cases with clinicopathologic correlation. Cancer. 1986 Jan 15;57(2):312-9. [PMID: 3002581]
17. Makdessian AS, Heathcote JG, Lampe HB. Cutaneous metastasis from a parotid adenoid cystic carcinoma arising in a
pleomorphic adenoma. J Otolaryngol. 1999 Jun;28(3):166-70. [PMID: 10410350]
18. Nakamura M, Miyachi Y. Cutaneous metastasis from an adenoid cystic carcinoma of the lacrimal gland. Br J Dermatol. 1999
Aug;141(2):373-4. [PMID: 10468832]
19. Chang CH, Liao YL, Hong HS. Cutaneous metastasis from adenoid cystic carcinoma of the parotid gland. Dermatol Surg.
2003 Jul;29(7):775-9. [PMID: 12828706]
20. Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E. Adenoid cystic carcinoma with high-grade transformation: a
report of 11 cases and a review of the literature. Am J Surg Pathol. 2007 Nov;31(11):1683-94. [PMID: 18059225]
21. Yurut-Caloglu V, Caloglu M, Ozyilmaz F, Saynak M, Cosar-Alas R, Karagol H, Bayir-Angin G, Uzal C. Lung, bone, skeletal
muscles and cutaneous metastases from adenoid cystic carcinoma of the parotid gland: a case report and review of the
literature. Med Oncol. 2007;24(4):458-62. [PMID: 17917100]
22. Park DY, Lee JH, Suh YL, Woo KI, Kim YD. Metastatic adenoid cystic carcinoma of the eyelid. Ophthal Plast Reconstr Surg.
2012 Sep-Oct;28(5):e111-2. [PMID: 22366665]
... Other factors that can also influence the prognosis of ACC are the size and location of the tumor, the type of therapy used, the dose of radiation, and the presence of metastasis [11,12]. The case presented had a late diagnosis reflecting an infiltrative lesion that compromised the right face in the medial and inferior portion of the maxillary sinus ascending to the medial margin of the orbit. ...
... The mutilation caused by delayed treatment of cancer in the region of the face can cause much inconvenience to the patient of aesthetic, functional, and emotional natures, impacting in the self-esteem and often leading to social isolation [12]. In the presented case, even after undergoing reconstructive surgery, the patient still had oroantral communication and sinking of the face on the right side. ...
Article
Full-text available
Adenoid cystic carcinoma is a cancer of the salivary gland that primarily affects the parotid, submandibular, and accessory salivary glands. Its growth is slow and it has infiltrative nature. A 46-year-old female patient coming from the rural area presented a lesion on the palate and reported pain in the region for three years. After incisional biopsy, and histopathological diagnosis of adenoid cystic carcinoma of the cribriform type of minor salivary gland, superior hemimaxillectomy and adjuvant treatment with radiotherapy and maxillofacial prosthetic rehabilitation were performed.
... This case highlights the aggressive nature of the tumour with an extremely poor prognosis following cutaneous spread. All 11 cases of salivary gland ACC with cutaneous metastasis reported in the literature were reviewed (Table 1) [10][11][12][13][14][15][16][17][18][19][20] . In all previous cases, cutaneous metastasis has occurred following metastasis to other tissue prior, most commonly to the lung and bone. ...
Article
Full-text available
Adenoid cystic carcinoma (ACC) is an aggressive salivary gland neoplasm characterized by high rates of local recurrence, early metastasis, and a poor long-term prognosis. Approximately 20-50% of cases result in distant metastasis, commonly involving the lung, bone, liver, and brain. Cutaneous metastasis is a rare occurrence, with a small number of cases reported previously in the context of multiple metastatic sites of involvement. We present a unique case of ACC of the hard palate with isolated cutaneous metastasis. A 36-year-old woman underwent a subtotal maxillectomy and skull base resection for the treatment of a T4N0 ACC of the right maxilla. One year postoperatively, the patient presented with multiple rapidly growing painful nodules on the skin of the scalp, neck, and chest. Biopsy confirmed metastatic poorly differentiated ACC, and positron emission tomography demonstrated cutaneous metastatic lesions without evidence of other tissue involvement. This case highlights the possible rare and aggressive pathways of metastasis of ACC. Currently there is no consensus for the treatment of disseminated disease, due to the poor efficacy of current treatment modalities. Where isolated metastasis is present, surgical resection can be attempted to control disease progression; however the benefit of metastasectomy on survival is not substantiated. As such, the role of newer targeted systemic therapies needs to be further investigated in the hope of achieving disease control.
... Other characteristic features of ACC include its slow growth and development of late distant metastasis (DM), sometimes even years after treatment of the primary tumor. These metastases most often occur in the lungs, but can also be seen in bones, brain, liver, scalp, thyroid, spleen, kidneys, omentum and pancreas [12][13][14][15][16]. Due to perineural invasion, DM and an increased recurrence rate, ACC shows poor long-term prognosis [17]. ...
Article
Background: The objective was to assess demographic and survival patterns in patients with adenoid cystic carcinoma of the base of tongue. Methods: Patients were extracted from the Surveillance, Epidemiology and End Results (SEER) database from 1973 through 2012 and were categorized by age, gender, race, historical stage A, and treatment. Incidence and survival were compared with Kaplan Meier curves and mortality hazard ratios. Results: A total of 216 patients were included. After adjusting for age, gender, race and tumor-directed treatment, patients over the age of 70years had a significantly increased mortality [HR=2.847, 95% CI (1.499, 5.404) p=0.0014]. Furthermore mortality among patients with distant disease was significantly increased [HR=2.474 95% CI (1.459, 4.195) p=0.00008]. Conclusion: By examining the largest collection of patients we have demonstrated that there is a significant difference in mortality based on both the age at diagnosis and in the setting of distant disease.
... Skin metastases of ACC are extremely rare; ACCs were previously reported as metastatic to skin, presenting as nodules on the neck, abdomen, shoulder, elbow, mental region, plantar surface, and digit nodules [3]. To the best of our knowledge, there is only one case of metastatic ACC of the submandibular gland to toes previously described in the literature; the patient in that case expired 10 months after the reported toe metastasis and 7 years after the initial diagnosis, with extensive metastatic disease [4]. ...
Article
Full-text available
Key Clinical Message Adenoid cystic carcinoma (ACC) is a rare malignant tumor of the salivary glands, with higher frequency in the submandibular gland, a prolonged clinical course, and poor long‐term survival. It tends to metastasize to lungs, bone, liver, brain, and rarely to skin. Comprehensive skin examination and appropriate follow‐up is recommended, since cutaneous metastasis represents disease progression, requiring management and prognosis adjustment.
Article
Full-text available
High-grade transformation of adenoid cystic carcinoma (ACC) (previously referred to as dedifferentiation) is a rare phenomenon that does not fit into the traditional ACC grading schemes. The importance and minimal criteria for distinction from solid (grade 111) ACC are not well established. We report I I new cases and review the literature to further define the profile of this tumor. The median age was 61 years (range: 32 to 72 y) with a male predominance (male to female ratio of 1.75: 1). The most commonly involved sites were sinonasal (4/11) and submandibular (4/11). Lymph nodes were pathologically positive in 4/7 (57.1 %) cases. Distant metastases to the lung (n = 2) and soft tissue of the shoulder (n = 1) were observed. Five of 9 patients (55.6%) died, all within 5 years with a median overall survival of 12 months. Histologically, ACC with high-grade transformation was distinguished from conventional ACC by nuclear enlargement and irregularity, higher mitotic counts, and the loss of the biphasic ductal-myoepithelial differentiation. Useful supportive criteria were prominent comedonecrosis and fibrocellular desmoplasia. The most common morphologies for the high-grade component were poorly differentiated cribriform adenocarcinoma and solid undifferentiated carcinoma. Micro-papillary and squamoid patterns were occasionally present. Ki-67 and p53 labeling indices were elevated in the high-grade components, though c-kit and cyclin-DI were not. ACC-high-grade transformation is a highly aggressive salivary gland tumor with a variety of histologic patterns. The high propensity for lymph node metastases suggests a role for neck dissection in patients with this rare tumor.
Article
Full-text available
Skin tumors are tumors arising from keratinocyte and from adnexal structures. Immunohistochemistry is very helpful in diagnosis of difficult cases in epithelial skin neoplasms, especially basal cell carcinoma (BCC) which is positive for BerEP4, a keratin marker, and mostly negative for epithelial membrane antigen (EMA). Squamous cell carcinoma cells are positive for EMA and cytokeratin, which are of higher molecular weight than those found in BCC. In contrast to BCC, trichoblastoma and trichoepithelioma are negative for androgen receptors. Of the malignant dermal spindle cell lesions, spindle cell squamous carcinoma is positive to 34 betaE12, desmoplasmic melanoma is positive to S100, and leiomyosarcoma is positive to desmin. Of the malignant pagetoid cells, Paget's disease is positive to CK7 and cam5.2, whereas the pagetoid variant of Bowen's disease is positive to CK 5/6. Melanoma in-situ is positive to both S100 and melan-A. Immunohistochemistry is an extremely valuable adjunct to standard morphologic diagnosis in diagnostic pathology. Diagnosis of epithelial tumor depends largely on morphological features but, in rare cases, immunohistochemical stains are needed for definitive diagnosis.
Article
Full-text available
We report a 58-year-old woman with cutaneous adenoid cystic carcinoma arising on the chest treated with Mohs micrographic surgery. The patient remained tumor-free at 24-month follow-up. To date, only six other cases of cutaneous adenoid cystic carcinoma were reportedly managed by Mohs surgery. Cutaneous adenoid cystic carcinoma has low potential for distant metastasis but is notorious for its aggressive infiltrative growth pattern, frequent perineural invasion, and high risk of local recurrence after excision. We propose that Mohs surgery is an ideal method to achieve margin-free removal of cutaneous adenoid cystic carcinoma. A brief literature review is provided.
Article
Primary cutaneous adenoid cystic carcinoma (ACC) is an uncommon malignancy with approximately 60 cases reported in the literature. Metastatic ACC to the skin is even less frequent with eight previously published cases, including only one arising from the lacrimal gland. We report a case of a 61-year-old male, who developed multiple cutaneous metastases to the scalp and back from a lacrimal gland ACC 21 years after the initial diagnosis. Initially, in the absence of the past clinical history, the cutaneous lesions were interpreted as primary ACC of the skin. Histopathologically, the metastatic lesions were poorly circumscribed dermal and subcutaneous nodules that were composed of islands of basaloid epithelial cells with ducts and cribriform pattern, mucinous stroma and prominent perineural invasion. Histomorphologically, the cutaneous tumors were similar to the primary ACC. The cutaneous metastases were preceded by tumor dissemination to the lung and other visceral organs, and ultimately led to patient's demise. This report illustrates the importance of juditious clinico-pathologic correlation and raises awareness regarding prolonged latency of cutaneous metastases in patients with visceral ACC.
Article
Background: Intermediary filaments are involved in cell motility and cancer progression. In a variety of organs, the expression of distinct intermediary filaments are associated with patient prognosis. In this study, we seeked to define the prognostic potential of cytokeratin and vimentin expression patterns in squamous cell carcinomas (SCC's) of the oral cavity. Methods: 308 patients with histologically proven and surgically treated squamous cell carcinomas of the oral cavity were investigated for the immunohistochemical expression of a variety of intermediary filaments including high- and low-molecular weight cytokeratins (Ck's), such as Ck 5/6, Ck 8/18, Ck 1, CK 10, Ck 14, Ck 19 and vimentin, using the tissue microarray technique. Correlations between clinical features and the expression of Cytokeratins and vimentin were evaluated statistically by Kaplan-Meier curves and multivariate Cox regression analysis. Results: The expression of Ck 8/18 and Ck 19 were overall significantly correlated with a poor clinical prognosis ( Ck 8/18 p = 0.04; Ck19 p < 0.01). These findings could also be reproduced for Ck 8/18 in primary nodal-negative SCC's and held true in multivariate-analysis. No significant correlation with patient prognosis could be found for the expression of the other cytokeratins and for vimentin. Conclusion: The expression of Ck 8/18 in SCC's of the oral cavity is an independent prognostic marker and indicates a decreased overall and progression free survival. These results provide an extended knowledge about the role of intermediary filament expression patterns in SCC's.
Article
A 48-year-old man presented with an enlarging mass of the right upper eyelid over a 1-month period. Nine years prior, the patient was diagnosed with adenoid cystic carcinoma (ACC) of the right maxillary sinus and underwent a total maxillectomy followed by local radiotherapy. Over the previous year, the patient had been treated with chemotherapy and radiotherapy for multiple organ metastases, including the spine, chest, and oral cavity. Ophthalmic examination revealed a white, round mass on the tarsal conjunctiva of the right upper eyelid, measuring approximately 1×1cm, and 2 palpable subcutaneous masses near the inferior orbital rim. Excisional biopsies of the masses were performed, and the histopathological findings were consistent with ACC with solid and cribriform patterns. Herein, the authors describe a case of metastatic ACC of the eyelid, which has not been described in the literature to their knowledge.
Article
Background: Adenoid cystic carcinoma (ACC) of the head and neck (ACCHN) is a rare tumor of minor salivary, parotid, and submandibular glands. The biologic behavior of the disease is poorly understood, and nonsurgical treatment strategies have yet to be standardized. The long-term prognosis continues to be guarded, with an estimated 10-year survival of <60%. Population-based studies examining ACC are scarce. The authors aimed to analyze incidence rates and survival outcomes for patients diagnosed with ACCHN using national population-based data. Methods: Data were obtained from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. Newly diagnosed ACCHN cases reported to SEER from 1973 through 2007 were categorized according to their sex, race, age, year of diagnosis, marital status, treatment interventions, primary tumor site, and disease stage. Incidence of ACCHN and postdiagnosis survival were examined over time and compared across different demographic and disease-related categories. Results: The authors identified 3026 patients with ACCHN. The mean age at diagnosis among those cases was 57.4 years (range, 11-99 years). Analyses of incidence data demonstrated a decline in ACCHN rates between 1973 and 2007, noted across all sexes and races with no detectable inflexion points. The overall 5-year, 10-year, and 15-year survival outcomes for ACCHN patients were 90.3%, 79.9%, and 69.2%, respectively. Females, patients with localized disease, and younger patients were found to have significantly better survival across all time periods (all comparison-specific log-rank P values <0.001). Multivariate analyses revealed better prognosis among women compared with men (hazard ratio [HR], 0.73; 95% confidence interval [CI], 0.65-0.82), among married compared with unmarried individuals (HR, 0.81; 95% CI, 0.71-0.91), with certain sites of origin and stage of disease (HR, 2.788; 95% CI, 2.36-3.29), and in those who had surgery of the primary tumor site (HR, 0.45; 95% CI, 0.37-0.54). Conclusions: The overall incidence of ACC is declining. The noted differences in survival based on sex, marital status, site of origin, and treatment intervention require further investigation.
Article
Forty-three examples of cribriform adenocarcinoma (adenoid cystic carcinoma) of mixed glandular origin are reported. Structural studies emphasise the classical cribriform pattern which indicates the capacity of this neoplasm to behave as both an epithelial and a connective tissue type tumour. In terms of survival, it does not appear to be an malignant as other forms of carcinoma arising in similar anatomical locations. The five-year crude survival rate (56%) compares favourably with that of other carcinomas of the palate and paranasal sinuses. A recurrence rate of the order of 20% may persist up to 10 years after primary treatment, and while this is not inimical to longer survival there is clearly a high morbidity.
Article
An unusual case of adenoid cystic carcinoma of the minor salivary glands of the nasal cavity metastasizing to the hand is presented. The problem of differentiating this lesion from the sweat gland tumor is described and the assistance of special stains is pointed out.
Article
A case of adenoid cystic carcinoma of the submaxillary gland metastatic to the left great toe in a 52-year-old man is reported. The patient survived 10 months after diagnosis of the metastasis to the hallux. The well-documented cases of four other patients, two each with pulmonary and renal-cell carcinoma metastatic to the toe, are reviewed. Metastatic carcinoma to the toe as well as the finger typically mimics an inflammatory process. An osteolytic lesion of the phalanx of a toe or finger resembling an inflammatory process without a history of injury or infection should suggest the possibility of malignancy.